bjective: Hepatic lipase (HL) is involved in the metabolism of several lipoproteins and has a key role in reverse cholesterol transport and atherosclerosis. The aim of this study was to evaluate the effects of HL -514C/T polymorphism on sub-clinical and established carotid atherosclerotic in hyperalphalipoproteinemic and control individuals. Methods: One hundred and sixty nine asymptomatic individuals (aged 47 ± 16 years), 71 hyperalphalipoproteinemic (Hyper-A, HDL-C ? 68mg/dL) and 98 controls (CTL, HDL-C 68mg/dL) were selected by clinical and laboratory evaluations. Lipids and lipoproteins were measured by enzymatic methods. HL activity was measured in post-heparin plasma by a radiometric assay and HL-514C/T genotypes were analyzed by PCR. Carotid intima-media thickness (cIMT) was measured by Doppler ultrasonography. Results: No differences in HL -514C/T genotype frequencies were observed between the groups. HL -514C/T polymorphism did not contribute to variations in cIMT or atherosclerotic lesion frequencies in Hyper-A and controls. Furthermore, no interactions between HL-514C/T polymorphism and cIMT or atherosclerotic lesions were found.Conclusions: In hyperalphalipoproteinemic individuals the -514C/T polymorphism is not associated with significant variations in HDL-Cholesterol concentrations. Besides, it has no repercussions on carotid atherosclerosis, although hepatic lipase activity is significantly reduced. © 2013 por la Sociedad Argentina de Endocrinologia y Metabolismo.503170175Hegele, R.A., Little, J.A., Vezina, C., Maguire, G.F., Tu, L., Wolever, T.S., Jenkins, D.J., Connelly, P.W., Hepatic lipase deficiency Clinical, biochemical, and molecular genetic characteristics (1993) Arterioscler Thromb, 13, pp. 720-728Santamarina-Fojo, S., Gonzalez-Navarro, H., Freeman, L., Wagner, E., Nong, Z., Hepatic lipase, lipoprotein metabolism, and atherogenesis (2004) Arterioscler Thromb Vasc Biol, 24, pp. 1750-1754Kontush, A., De Faria, E.C., Chantepie, S., Chapman, M.J., Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: Relevance of enzymatic and physicochemical properties (2004) Arterioscler Thromb Vasc Biol, 24, pp. 526-533Inazu, A., Brown, M.L., Hesler, C.B., Agellon, L.B., Koizumi, J., Takata, K., Maruhama, Y., Tall, A.R., Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation (1990) N Engl J Med, 323, pp. 1234-1238Hirano, K., Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase (1995) Arterioscler Thromb Vasc Biol, 15, pp. 1849-1856Jansen, H., Verhoeven, A.J., Weeks, L., Kastelein, J.J., Halley, D.J., Van Den Ouweland, A., Jukema, J.W., Birkenhager, J.C., Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients (1997) Arterioscler Thromb Vasc Biol, 17, pp. 2837-2842Bos, G., Dekker, J.M., Feskens, E.J., Ocke, M.C., Nijpels, G., Stehouwer, C.D., Bouter, L.M., Jansen, H., Interactions of dietary fat intake and the hepatic lipase -480C-T polymorphism in determining hepatic lipase activity: The Hoorn Study (2005) The American Journal of Clinical Nutrition, 81, pp. 911-915Kimura, H., Miyazaki, R., Imura, T., Masunaga, S., Suzuki, S., Gejyo, F., Yoshida, H., Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels (2003) Kidney International, 64, pp. 1829-1837McCaskie, P.A., Cadby, G., Hung, J., McQuillan, B.M., Chapman, C.M., Carter, K.W., Thompson, P.L., Beilby, J.P., The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease (2006) Clinical Genetics, 70, pp. 14-121Zhang, C., Lopez-Ridaura, R., Rimm, E.B., Rifai, N., Hunter, D.J., Hu, F.B., Interactions between the -514C-T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men (2005) The American Journal of Clinical Nutrition, 81, pp. 1429-1435Rundek, T., Elkind, M.S., Pittman, J., Boden-Albala, B., Martin, S., Humphries, S.E., Juo, S.H., Sacco, R.L., Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: The northern manhattan prospective cohort study (2002) StrokeA Journal of Cerebral Circulation, 33, pp. 1420-1423Burdon, K.P., Langefeld, C.D., Beck, S.R., Wagenknecht, L.E., Carr, J.J., Freedman, B.I., Herrington, D., Bowden, D.W., Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study (2005) J Med Genet, 42, pp. 720-724Isaacs, A., Sayed-Tabatabaei, F.A., Hofman, A., Oostra, B.A., Klungel, O.H., Maitland-Vander Zee, A.H., Stricker, B.H., Van Duijn, C.M., The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: The Rotterdam Study (2007) Eur J Cardiovasc Prev Rehabil, 14, pp. 419-421Expert panel on detection e, treatment of high blood cholesterol in A. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Adult Treatment Panel III) (2001) JAMA : The Journal of the American Medical Association, 285, pp. 2486-2497Sposito, A.C., IV Brazilian Guideline for Dyslipidemia and Atherosclerosis prevention: Department of Atherosclerosis of Brazilian Society of Cardiology (2007) Arq Bras Cardiol, 88 (SUPPL.1), pp. 2-19Eyre, J., Hammett, F., Miller, N.E., A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions (1981) HDL2 and HDL3. Clin Chim Acta, 114, pp. 225-231Ehnholm, C., Kuusi, T., Preparation, characterization, and measurement of hepatic lipase (1986) Methods Enzymol, 129, pp. 716-738Salazar, L.A., Melo, C.E., Cavalli, S.A., Hinuy, H.M., Hirata, M.H., Hirata, R.D.C., Micrométodo para extracäo de DNA genômico util no diagnóstico molecu lar da Hipercolesterolemia Familial (2001) Rev Bras Anal Clin, 33, pp. 111-116Simons, P.C., Algra, A., Bots, M.L., Grobbee, D.E., Van Der Graaf, Y., Common carotid intima-media thickness and arterial stiffness: Indicators of cardiovascular risk in high-risk patients the SMART Study (Second Manifestations of ARTerial disease) (1999) Circulation, 100, pp. 951-957Chambless, L.E., Heiss, G., Folsom, A.R., Rosamond, W., Szklo, M., Sharrett, A.R., Clegg, L.X., Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study 1987-1993 (1997) Am J Epidemiol, 146, pp. 483-494Vega, G.L., Clark, L.T., Tang, A., Marcovina, S., Grundy, S.M., Cohen, J.C., Hepatic lipase activity is lower in African American men than in white American men: Effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC) (1998) Journal of Lipid Research, 39, pp. 228-232Nie, L., Wang, J., Clark, L.T., Tang, A., Vega, G.L., Grundy, S.M., Cohen, J.C., Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity (1998) Journal of Lipid Research, 39, pp. 1127-1130Grundy, S.M., Vega, G.L., Otvos, J.D., Rainwater, D.L., Cohen, J.C., Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence (1999) Journal of Lipid Research, 40, pp. 229-234Hong, S.H., Song, J., Kim, J.Q., Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease (2000) Clinical Biochemistry, 33, pp. 291-296Zambon, A., Deeb, S.S., Brown, B.G., Hokanson, J.E., Brunzell, J.D., Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment (2001) Circulation, 103, pp. 792-798Somekawa, Y., Umeki, H., Kobayashi, K., Tomura, S., Aso, T., Hamaguchi, H., Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women (2002) The Journal of Clinical Endocrinology and Metabolism, 87, pp. 4766-4770Yamakawa-Kobayashi, K., Somekawa, Y., Fujimura, M., Tomura, S., Arinami, T., Hamaguchi, H., Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy (2002) Atherosclerosis, 162, pp. 17-21Fan, Y.M., Laaksonen, R., Janatuinen, T., Vesalainen, R., Laine, H., Raitakari, O.T., Nuutila, P., Lehtimaki, T., The influence of hepatic lipase C-480T polymorphism on coronary flow reserve in young men is independent of the plasma cholesterol level (2006) Atherosclerosis, 188, pp. 391-397Couture, P., Otvos, J.D., Cupples, L.A., Lahoz, C., Wilson, P.W., Schaefer, E.J., Ordovas, J.M., Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study (2000) Arterioscler Thromb Vasc Biol, 20, pp. 815-822Murtomaki, S., Tahvanainen, E., Antikainen, M., Tiret, L., Nicaud, V., Jansen, H., Ehnholm, C., Hepatic lipase gene polymorphisms influence plasma HDL levels Results from finnish ears participants. European atherosclerosis research study (1997) Arterioscler Thromb Vasc Biol, 17, pp. 1879-1884Zambon, A., Deeb, S.S., Hokanson, J.E., Brown, B.G., Brunzell, J.D., Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol (1998) Arterioscler Thromb Vasc Biol, 18, pp. 1723-1729Tahvanainen, E., Syvanne, M., Frick, M.H., Murtomaki-Repo, S., Antikainen, M., Kesaniemi, Y.A., Kauma, H., Ehnholm, C., Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators (1998) The Journal of Clinical Investigation, 101, pp. 956-960Hegele, R.A., Harris, S.B., Brunt, J.H., Young, T.K., Hanley, A.J., Zinman, B., Connelly, P.W., Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations (1999) Atherosclerosis, 146, pp. 153-160Kuusi, T., Saarinen, P., Nikkila, E.A., Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man (1980) Atherosclerosis, 36, pp. 589-593Faggin, E., Zambon, A., Puato, M., Deeb, S.S., Bertocco, S., Sartore, S., Crepaldi, G., Pauletto, P., Association between the -514 C-T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis (2002) J Am Coll Cardiol, 40, pp. 1059-1066Zambon, A., Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: Impact of plaque composition and lipoprotein phenotype (2006) Atherosclerosis, 185, pp. 121-126Fan, Y.M., Dastidar, P., Jokela, H., Punnonen, R., Lehtimaki, T., Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women (2005) The Journal of Clinical Endocrinology and Metabolism, 90, pp. 3786-3792Fan, Y.M., Raitakari, O.T., Kahonen, M., Hutri-Kahonen, N., Juonala, M., Marniemi, J., Viikari, J., Lehtimaki, T., Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: The Cardiovascular risk in young finns study (2009) Clinical Genetics, 76, pp. 46-53